c2c12 cell line Search Results


94
Genecopoeia c2c12 cells
C2c12 Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/Human+cell+line+C2C12+stably+expressing+CRISPR+Cas9%2C+randomly+inserted%2C+single+clone/pm29175376-52-3-28
Average 94 stars, based on 1 article reviews
c2c12 cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Dainippon Sumitomo c2c12 murine skeletal muscle cell line
Distribution of estrogen receptors in various organs and tissues of adult mouse. a Western blot analysis of whole-cell fractions with a specific monoclonal estrogen receptor (ER) antibody. Upper panel immunoreactive bands corresponding to the ER protein (66 kDa). The histogram (lower) indicates the results of densitometric analysis for a 66-kDa band (mean ± SE, n = 4). Relative expression level with respect to the ovary is shown in %. From left to right: skeletal muscle, uterus, lung, adipose tissue, kidney, and myocardium. b Relative expression (to ovary) of whole cell and nonnuclear ER proteins obtained from <t>C2C12</t> mouse myoblasts (n = 3)
C2c12 Murine Skeletal Muscle Cell Line, supplied by Dainippon Sumitomo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+murine+skeletal+muscle+cell+line/pmc10717592-94-0-11
Average 90 stars, based on 1 article reviews
c2c12 murine skeletal muscle cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank murine c2c12 myoblast cells
IgLON expressions in murine <t>C2C12</t> myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Murine C2c12 Myoblast Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+cells/pmc09601278-32-0-4
Average 90 stars, based on 1 article reviews
murine c2c12 myoblast cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Interlab Inc mouse myoblast c2c12 cell line
IgLON expressions in murine <t>C2C12</t> myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Mouse Myoblast C2c12 Cell Line, supplied by Interlab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/mouse+myoblast+c2c12+cell+line/pm38901103-135-1-9
Average 90 stars, based on 1 article reviews
mouse myoblast c2c12 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pasteur Institute mouse skeletal myoblast cell line c2c12
IgLON expressions in murine <t>C2C12</t> myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Mouse Skeletal Myoblast Cell Line C2c12, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+cell+line/pmc09277013-71-1-12
Average 90 stars, based on 1 article reviews
mouse skeletal myoblast cell line c2c12 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank c 2 c 12 mouse myoblasts
IgLON expressions in murine <t>C2C12</t> myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
C 2 C 12 Mouse Myoblasts, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c+2+c+12+mouse+myoblasts/pmc10164918-25-9-14
Average 90 stars, based on 1 article reviews
c 2 c 12 mouse myoblasts - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell c2c12 myoblasts (a mouse cell line)
Evaluation of the biocompatibility of W-GA in vitro. ( a ) <t>C2C12</t> cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant
C2c12 Myoblasts (A Mouse Cell Line), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+myoblasts++a+mouse+cell+line+/pmc11757907-52-0-9
Average 90 stars, based on 1 article reviews
c2c12 myoblasts (a mouse cell line) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank mouse c2c12 muscle cells c2c12
Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into <t>C2C12</t> cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01
Mouse C2c12 Muscle Cells C2c12, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/mouse+myoblast+cell+line+c2c12/pmc04966724-57-0-22
Average 90 stars, based on 1 article reviews
mouse c2c12 muscle cells c2c12 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioResource International Inc myoblast cell line c 2 c 12
Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into <t>C2C12</t> cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01
Myoblast Cell Line C 2 C 12, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/myoblast+cell+line+c+2+c+12/pmc07949697-48-0-27
Average 90 stars, based on 1 article reviews
myoblast cell line c 2 c 12 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
MARINPHARM gmbh mouse myoblast cell line c2c12
Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into <t>C2C12</t> cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01
Mouse Myoblast Cell Line C2c12, supplied by MARINPHARM gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/mouse+myoblast+cell+line+c2c12/pmc06399612-939-4-8
Average 90 stars, based on 1 article reviews
mouse myoblast cell line c2c12 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Funakoshi ltd c2c12 murine myogenic cell line
Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into <t>C2C12</t> cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01
C2c12 Murine Myogenic Cell Line, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+murine+myogenic+cell+line/pm27349543-23-8-13
Average 90 stars, based on 1 article reviews
c2c12 murine myogenic cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cowin Biosciences c2c12 cell line
A The schematic diagram of cell migration assay. <t>C2C12</t> cells were seeded in the four wells in a 35-nm dish. After treatment, the culture insert was removed, then the dish was observed in a live cell workstation. B The images of cell migration at 0, 360, 1605, and 2655 min. The yellow arrows indicate the loaded cells under migration and the blue arrows indicate unloaded cells under migration. C Schematic diagram of counting the number of migrating cells. D The number of migrating cells at 24 and 48 h. E The microfilaments and LDs were marked in loaded and unloaded cells. The arrows indicate the pseudopodia in loaded cells and the arrow head indicate the pseudopodia in unloaded cells. F The number of filpopdia in E ( N = 30). * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).
C2c12 Cell Line, supplied by Cowin Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c2c12+cell+line/c2c12+cell+line/pmc08611090-27-1-7
Average 90 stars, based on 1 article reviews
c2c12 cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Distribution of estrogen receptors in various organs and tissues of adult mouse. a Western blot analysis of whole-cell fractions with a specific monoclonal estrogen receptor (ER) antibody. Upper panel immunoreactive bands corresponding to the ER protein (66 kDa). The histogram (lower) indicates the results of densitometric analysis for a 66-kDa band (mean ± SE, n = 4). Relative expression level with respect to the ovary is shown in %. From left to right: skeletal muscle, uterus, lung, adipose tissue, kidney, and myocardium. b Relative expression (to ovary) of whole cell and nonnuclear ER proteins obtained from C2C12 mouse myoblasts (n = 3)

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Distribution of estrogen receptors in various organs and tissues of adult mouse. a Western blot analysis of whole-cell fractions with a specific monoclonal estrogen receptor (ER) antibody. Upper panel immunoreactive bands corresponding to the ER protein (66 kDa). The histogram (lower) indicates the results of densitometric analysis for a 66-kDa band (mean ± SE, n = 4). Relative expression level with respect to the ovary is shown in %. From left to right: skeletal muscle, uterus, lung, adipose tissue, kidney, and myocardium. b Relative expression (to ovary) of whole cell and nonnuclear ER proteins obtained from C2C12 mouse myoblasts (n = 3)

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques: Western Blot, Expressing

Time course of ER mRNA and protein expression during E2 exposure. a Representative of C2C12 mRNA transcripts for ER and GAPDH at several time points after exposure to E2 (10−8 M) (upper). The mRNA level of ER relative to GAPDH is averaged from five individual experiments and displayed as mean ± SE (statistically significant). At 0, 0.5, 1, 3, and 5 h (lower). b Proteins were extracted from nucleus-free C2C12 cells exposed to E2 (10−8 M) for varying periods of time (from left: 0, 1, 3, 4, 6, 12, and 24 h) and immunoblotted with the ER antibody. Immunodensity in a 66-kDa band is quantified by densitometry and presented as the % increase of control (time 0). Symbols and bars represent mean ± SE (n = 5); statistically significant

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Time course of ER mRNA and protein expression during E2 exposure. a Representative of C2C12 mRNA transcripts for ER and GAPDH at several time points after exposure to E2 (10−8 M) (upper). The mRNA level of ER relative to GAPDH is averaged from five individual experiments and displayed as mean ± SE (statistically significant). At 0, 0.5, 1, 3, and 5 h (lower). b Proteins were extracted from nucleus-free C2C12 cells exposed to E2 (10−8 M) for varying periods of time (from left: 0, 1, 3, 4, 6, 12, and 24 h) and immunoblotted with the ER antibody. Immunodensity in a 66-kDa band is quantified by densitometry and presented as the % increase of control (time 0). Symbols and bars represent mean ± SE (n = 5); statistically significant

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques: Expressing, Control

Dose–dependent effects of 17β-estradiol on the expression of total and nonnuclear ER. Representative immunoreactive bands for total ER in C2C12 myoblasts (upper panel) and the relative expression of total ER protein (a) or nonnuclear ER protein (b) quantified by densitometric analysis (lower panel); after treatment with either vehicle (control), different concentrations of 17β-estradiol (10−12–10−5 M) in a and (10−10–10−6 M) in b for 15 h. c Shows the relative expression of total ER protein after treatment with vehicle (control), 17β-estradiol (10−8 M), and BSA-conjugated E2 (10−8 M) for 15 h. Each bar is normalized to the control (far left) and expressed as %. Columns and bars indicate mean ± SE (n = 3 in a, n = 4 in b, and n = 5 in c). *P < 0.01, ☆ P < 0.05 compared with control values, determined using Student’s t test

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Dose–dependent effects of 17β-estradiol on the expression of total and nonnuclear ER. Representative immunoreactive bands for total ER in C2C12 myoblasts (upper panel) and the relative expression of total ER protein (a) or nonnuclear ER protein (b) quantified by densitometric analysis (lower panel); after treatment with either vehicle (control), different concentrations of 17β-estradiol (10−12–10−5 M) in a and (10−10–10−6 M) in b for 15 h. c Shows the relative expression of total ER protein after treatment with vehicle (control), 17β-estradiol (10−8 M), and BSA-conjugated E2 (10−8 M) for 15 h. Each bar is normalized to the control (far left) and expressed as %. Columns and bars indicate mean ± SE (n = 3 in a, n = 4 in b, and n = 5 in c). *P < 0.01, ☆ P < 0.05 compared with control values, determined using Student’s t test

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques: Expressing, Control

Influence of 17-βestradiol on C2C12 proliferation. C2C12 cells were grown in the serum-free medium for 48 h, which was then changed to ones with or without E2 (10−8 M) in 1% FBS (open triangle, closed triangle) or 10% FBS (open circle, closed circle). The rate of cell growth is shown as the cell number at every 24 h relative to 0 h. Symbols and bars represent the mean ± SE (n = 5)

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Influence of 17-βestradiol on C2C12 proliferation. C2C12 cells were grown in the serum-free medium for 48 h, which was then changed to ones with or without E2 (10−8 M) in 1% FBS (open triangle, closed triangle) or 10% FBS (open circle, closed circle). The rate of cell growth is shown as the cell number at every 24 h relative to 0 h. Symbols and bars represent the mean ± SE (n = 5)

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques:

Effects of ER antagonists on E2-induced whole-cell and non-nuclear ER increase. C2C12 cells were treated with E2 (10−8 M) in the absence or presence of either tamoxifen or ICI 182,780 (10−7 M; a total ER) or (10−5 M; b non-nuclear fractions) for 15 h. Tamoxifen or ICI 182,780 was added to the culture medium 30 min prior to the administration of E2. Total and nonnuclear fractions of ER were prepared as described in “Materials and methods” and subjected to Western blotting. Histograms represent the extent of inhibition of E2-induced ER increase in total a and nonnuclear b fractions, which are expressed as the percentage of control (no stimulation), averaged from five separate experiments (mean ± SE). *P < 0.01, compared with control values, determined using Student’s t test

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Effects of ER antagonists on E2-induced whole-cell and non-nuclear ER increase. C2C12 cells were treated with E2 (10−8 M) in the absence or presence of either tamoxifen or ICI 182,780 (10−7 M; a total ER) or (10−5 M; b non-nuclear fractions) for 15 h. Tamoxifen or ICI 182,780 was added to the culture medium 30 min prior to the administration of E2. Total and nonnuclear fractions of ER were prepared as described in “Materials and methods” and subjected to Western blotting. Histograms represent the extent of inhibition of E2-induced ER increase in total a and nonnuclear b fractions, which are expressed as the percentage of control (no stimulation), averaged from five separate experiments (mean ± SE). *P < 0.01, compared with control values, determined using Student’s t test

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques: Western Blot, Inhibition, Control

Effects of 17β-estradiol and/or TPA on ER de novo synthesis. In the absence (control) or presence of 17β-estradiol (10−8 M) and/or TPA (10−6 M), C2C12 cells were labeled with [35S] methionine. At the time points indicated in the figure, the total ER fractions were prepared and subjected to selective immunoprecipitation for ER. The immunoprecipitates were analyzed by SDS-PAGE and image scanning. Data are the mean ± SE from three separate experiments. Left panel time course of 35methionine incorporation in ER. Right panel rates of the increase at 5 h by the relative ratio of control. *P < 0.01, compared with control values, determined using Student’s t test. ☆ P < 0.01, compared with E2 values, determined using Student’s t test

Journal: The Journal of Physiological Sciences : JPS

Article Title: 17β-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts

doi: 10.1007/s12576-009-0023-0

Figure Lengend Snippet: Effects of 17β-estradiol and/or TPA on ER de novo synthesis. In the absence (control) or presence of 17β-estradiol (10−8 M) and/or TPA (10−6 M), C2C12 cells were labeled with [35S] methionine. At the time points indicated in the figure, the total ER fractions were prepared and subjected to selective immunoprecipitation for ER. The immunoprecipitates were analyzed by SDS-PAGE and image scanning. Data are the mean ± SE from three separate experiments. Left panel time course of 35methionine incorporation in ER. Right panel rates of the increase at 5 h by the relative ratio of control. *P < 0.01, compared with control values, determined using Student’s t test. ☆ P < 0.01, compared with E2 values, determined using Student’s t test

Article Snippet: C2C12 murine skeletal muscle cell line [ 20 ], obtained from Dainippon Pharmaceutical Ltd., was routinely cultured in Dulbecco’s Modified Eagle’s Medium F12 (DMEM/F12) containing 10% heat-inactivated (30 min, 56°C) fetal bovine serum (FBS).

Techniques: Control, Labeling, Immunoprecipitation, SDS Page

IgLON expressions in murine C2C12 myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: IgLON expressions in murine C2C12 myoblasts and primary MSCs during myogenic differentiation, and IgLON4 protein expression in regenerating mouse muscle: ( A ) mRNA and protein expressions of IgLONs (IgLON1 to 5) in C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 on DD2 as determined by Western blot. Locations of IgLON4 protein were determined by immunocytochemistry. ( B ) mRNA expressions of IgLONs in mouse primary MSCs on DD2 as determined by real-time RT-PCR, and protein expressions of IgLON4 and 5 as determined by Western blot analysis. ( C ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation days 3 and 7), as determined by immunofluorescence; muscle was collected and embedded with paraffin and then stained with IgLON4 and laminin (Green: IgLON4, Red: Laminin, Blue: Nucleus). ( D ) Expressions of IgLON4 in control and CTX-injected mouse gastrocnemius muscles during regeneration (differentiation day 7), as determined by H&E staining and immunohistochemistry. Protein expressions of PAX7 and IgLON4 were determined by Western blot analysis. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t -test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Immunocytochemistry, Control, Injection, Muscles, Immunofluorescence, Staining, Immunohistochemistry, Real-time Polymerase Chain Reaction

Inhibitory effect of IgLON4 gene and protein expression on C2C12 myoblast differentiation: ( A ) mRNA and protein expressions of IgLON4 as determined by real-time RT-PCR and Western blot analysis in Wt and IgLON4 kd C2C12 myoblasts on differentiation days (DDs) 2, 4, and 6. mRNA levels on DDs 2, 4 and 6 were normalized versus Wt levels. ( B ) Expression of MYH by immunocytochemistry in Wt and IgLON4 kd C2C12 myoblasts on DD4, and IgLON4 kd fusion indices. ( C ) mRNA and protein levels of MYOD, IgLON5, MYOG, and MYH as determined by real-time RT-PCR and Western blot analysis in Wt and IgLON4 kd cells on DDs 2, 4, and 6. mRNA and protein levels were compared at each time point. ( D ) Morphologies of cells treated with or without IgLON4 antibody on DD2 or 4. mRNA and protein expressions of IgLON4, IgLON5, MYOD, MYOG, and MYH in cells treated with or without IgLON4 antibody on DDs 2 or 4. mRNA and protein levels at each time-point were compared. Wt indicates transfection with scrambled vector. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: Inhibitory effect of IgLON4 gene and protein expression on C2C12 myoblast differentiation: ( A ) mRNA and protein expressions of IgLON4 as determined by real-time RT-PCR and Western blot analysis in Wt and IgLON4 kd C2C12 myoblasts on differentiation days (DDs) 2, 4, and 6. mRNA levels on DDs 2, 4 and 6 were normalized versus Wt levels. ( B ) Expression of MYH by immunocytochemistry in Wt and IgLON4 kd C2C12 myoblasts on DD4, and IgLON4 kd fusion indices. ( C ) mRNA and protein levels of MYOD, IgLON5, MYOG, and MYH as determined by real-time RT-PCR and Western blot analysis in Wt and IgLON4 kd cells on DDs 2, 4, and 6. mRNA and protein levels were compared at each time point. ( D ) Morphologies of cells treated with or without IgLON4 antibody on DD2 or 4. mRNA and protein expressions of IgLON4, IgLON5, MYOD, MYOG, and MYH in cells treated with or without IgLON4 antibody on DDs 2 or 4. mRNA and protein levels at each time-point were compared. Wt indicates transfection with scrambled vector. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Immunocytochemistry, Transfection, Plasmid Preparation, Real-time Polymerase Chain Reaction, Control

Differentiation, adhesion, and proliferation of Wt, IgLON4 kd , IgLON5 kd , and Db kd C2C12 myoblasts: ( A ) The mRNA and protein expressions of IgLON4 and IgLON5 in Wt and Db kd C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR and Western blot. ( B ) mRNA and protein expressions of MYOD, MYOG, and MYH in Wt and Db kd cells on DDs 2, 4, or 6 as determined by real-time RT-PCR and Western blot analysis. mRNA and protein levels were compared at each time point. ( C ) Wt and Db kd C2C12 myoblast morphologies, MYH expressions (as determined by immunocytochemistry), and fusion indices of Db kd cells on DD4. ( D , E ) MTS assays were used to assess Wt, IgLON4 kd , IgLON5 kd , and Db kd C2C12 myoblast cell adhesions and proliferation after differentiation for 3 h or 3 days, respectively. ( F ) Wt, IgLON4 kd , IgLON5 kd , and Db kd cells were cultured until 30% or 100% confluent, or for 4 days. Plates were then sealed and placed inverted and centrifuged using a swinging bucket rotor at 100×, 500×, or 1000× g . Relative cell counts after centrifugation, as assessed by MTS assay and normalized versus initial cell numbers (before centrifugation). Wt indicates transfection with a scrambled vector. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: Differentiation, adhesion, and proliferation of Wt, IgLON4 kd , IgLON5 kd , and Db kd C2C12 myoblasts: ( A ) The mRNA and protein expressions of IgLON4 and IgLON5 in Wt and Db kd C2C12 myoblasts on differentiation day 2 (DD2) as determined by real-time RT-PCR and Western blot. ( B ) mRNA and protein expressions of MYOD, MYOG, and MYH in Wt and Db kd cells on DDs 2, 4, or 6 as determined by real-time RT-PCR and Western blot analysis. mRNA and protein levels were compared at each time point. ( C ) Wt and Db kd C2C12 myoblast morphologies, MYH expressions (as determined by immunocytochemistry), and fusion indices of Db kd cells on DD4. ( D , E ) MTS assays were used to assess Wt, IgLON4 kd , IgLON5 kd , and Db kd C2C12 myoblast cell adhesions and proliferation after differentiation for 3 h or 3 days, respectively. ( F ) Wt, IgLON4 kd , IgLON5 kd , and Db kd cells were cultured until 30% or 100% confluent, or for 4 days. Plates were then sealed and placed inverted and centrifuged using a swinging bucket rotor at 100×, 500×, or 1000× g . Relative cell counts after centrifugation, as assessed by MTS assay and normalized versus initial cell numbers (before centrifugation). Wt indicates transfection with a scrambled vector. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Quantitative RT-PCR, Western Blot, Immunocytochemistry, Cell Culture, Centrifugation, MTS Assay, Transfection, Plasmid Preparation, Real-time Polymerase Chain Reaction, Control

IgLON4 protein expression and myotube orientation in Wt and IgLON4 kd C2C12 myoblasts during differentiation: ( A ) IgLON4 protein locations were determined by immunocytochemistry on differentiation days (DDs) 2 and 4. Phalloidin and IgLON4 were fluorescently labeled green and red, respectively. Phalloidin was used for counterstaining cytoskeletal actin filaments. ( B ) Myotube formation was observed by MYH immunocytochemistry in Wt and IgLON4 kd cells on DD4. Directional analysis of myotube formation by Wt and IgLON4 kd cells was performed using ImageJ on DD4. Wt indicates transfection with a scrambled vector.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: IgLON4 protein expression and myotube orientation in Wt and IgLON4 kd C2C12 myoblasts during differentiation: ( A ) IgLON4 protein locations were determined by immunocytochemistry on differentiation days (DDs) 2 and 4. Phalloidin and IgLON4 were fluorescently labeled green and red, respectively. Phalloidin was used for counterstaining cytoskeletal actin filaments. ( B ) Myotube formation was observed by MYH immunocytochemistry in Wt and IgLON4 kd cells on DD4. Directional analysis of myotube formation by Wt and IgLON4 kd cells was performed using ImageJ on DD4. Wt indicates transfection with a scrambled vector.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Expressing, Immunocytochemistry, Labeling, Transfection, Plasmid Preparation

Locations of IgLON4 protein and lipid rafts on membranes, and the inhibitory effects of IgLON4 mRNA and protein on lipid raft during myoblast differentiation: ( A ) Locations of IgLON4 protein and lipid rafts as determined by immunocytochemistry on DD2. ( B ) Locations of IgLON5, NCAM, and CDH15 proteins and lipid rafts as determined by immunocytochemistry on DD2. ( C ) mRNA and protein expressions of NCAM, CDH15, WASP, CAV1, CAV2, CAV3, and FLOT1 in Wt and IgLON4 kd C2C12 myoblasts on DD2 as determined by real-time RT-PCR and Western blot analysis. ( D ) Extraction of lipid rafts from Wt and IgLON4 kd C2C12 myoblasts on DD2, and the protein expressions of IgLON4, IgLON5, CDH15, and FLOT1 by Western blot analysis. FLOT1 and β-actin were used as markers of lipid rafts and total cell lysates, respectively. ( E ) Locations of IgLON4 protein and lipid rafts in C2C12 myoblasts treated with or without IgLON4 antibody as determined by immunocytochemistry on DD2. Wt indicates transfection with a scrambled vector. Lipid rafts were labeled green using cholera toxin and IgLON4, IgLON5, NCAM, and CDH15 were labeled red using Alexa Fluor 594. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: Locations of IgLON4 protein and lipid rafts on membranes, and the inhibitory effects of IgLON4 mRNA and protein on lipid raft during myoblast differentiation: ( A ) Locations of IgLON4 protein and lipid rafts as determined by immunocytochemistry on DD2. ( B ) Locations of IgLON5, NCAM, and CDH15 proteins and lipid rafts as determined by immunocytochemistry on DD2. ( C ) mRNA and protein expressions of NCAM, CDH15, WASP, CAV1, CAV2, CAV3, and FLOT1 in Wt and IgLON4 kd C2C12 myoblasts on DD2 as determined by real-time RT-PCR and Western blot analysis. ( D ) Extraction of lipid rafts from Wt and IgLON4 kd C2C12 myoblasts on DD2, and the protein expressions of IgLON4, IgLON5, CDH15, and FLOT1 by Western blot analysis. FLOT1 and β-actin were used as markers of lipid rafts and total cell lysates, respectively. ( E ) Locations of IgLON4 protein and lipid rafts in C2C12 myoblasts treated with or without IgLON4 antibody as determined by immunocytochemistry on DD2. Wt indicates transfection with a scrambled vector. Lipid rafts were labeled green using cholera toxin and IgLON4, IgLON5, NCAM, and CDH15 were labeled red using Alexa Fluor 594. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SDs ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Immunocytochemistry, Quantitative RT-PCR, Western Blot, Extraction, Transfection, Plasmid Preparation, Labeling, Real-time Polymerase Chain Reaction, Control

Effect of using striped culture plates on C2C12 myoblasts differentiation: ( A ) The formation of myotubes in normal and striped plate cultures was observed by MYH immunocytochemistry. ( B ) mRNA and protein expressions of myogenic markers, muscle-specific adhesion proteins, and IgLON family members in C2C12 myoblasts cultured in normal and striped plates on DD2 and 4 as determined by real-time RT-PCR and Western blot analysis. ( C ) Location of IgLON4 protein as determined by immunocytochemistry on DD2 in C2C12 myoblasts cultured on striped plates. Labeling was performed using fluorescently labeled phalloidin and IgLON4 (green and red, respectively). Phalloidin was used to counterstain cytoskeletal actin filaments. ( D ) Locations of lipid rafts and IgLON4 protein as determined by immunocytochemistry on DD2. Lipid rafts were stained using labeled cholera toxin (green fluorescence) and IgLON4 with Alexa Fluor 594 (red fluorescence). ( E ) Morphologies of C2C12 myoblasts treated with or without IgLON4 antibody on DD2. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Cells

Article Title: IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation

doi: 10.3390/cells11203265

Figure Lengend Snippet: Effect of using striped culture plates on C2C12 myoblasts differentiation: ( A ) The formation of myotubes in normal and striped plate cultures was observed by MYH immunocytochemistry. ( B ) mRNA and protein expressions of myogenic markers, muscle-specific adhesion proteins, and IgLON family members in C2C12 myoblasts cultured in normal and striped plates on DD2 and 4 as determined by real-time RT-PCR and Western blot analysis. ( C ) Location of IgLON4 protein as determined by immunocytochemistry on DD2 in C2C12 myoblasts cultured on striped plates. Labeling was performed using fluorescently labeled phalloidin and IgLON4 (green and red, respectively). Phalloidin was used to counterstain cytoskeletal actin filaments. ( D ) Locations of lipid rafts and IgLON4 protein as determined by immunocytochemistry on DD2. Lipid rafts were stained using labeled cholera toxin (green fluorescence) and IgLON4 with Alexa Fluor 594 (red fluorescence). ( E ) Morphologies of C2C12 myoblasts treated with or without IgLON4 antibody on DD2. Real-time PCR results were normalized to each control (con, before differentiation) and analyzed by t-test. Means ± SD ( n ≥ 3). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Murine C2C12 myoblast cells (Korean Cell Line Bank, Seoul, Korea) were cultured in growth media DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% FBS (Fetal Bovine Serum) and 1% P/S (penicillin/streptomycin; all were purchased from Hyclone, South Logan, UT, USA) in a humidified 5% CO 2 incubator at 37 °C.

Techniques: Immunocytochemistry, Cell Culture, Quantitative RT-PCR, Western Blot, Labeling, Staining, Fluorescence, Real-time Polymerase Chain Reaction, Control

Evaluation of the biocompatibility of W-GA in vitro. ( a ) C2C12 cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant

Journal: Burns & Trauma

Article Title: Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes

doi: 10.1093/burnst/tkae059

Figure Lengend Snippet: Evaluation of the biocompatibility of W-GA in vitro. ( a ) C2C12 cells cultured for 7 days in W-GA were evaluated for proliferation and cytotoxicity using live/dead staining. Scale bar = 500 μm. ( b ) Survival rate of C212 cells ( n = 3) is shown as the mean ± standard deviation. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant. ( c ) C2C12 cell proliferation capacity was assessed 24 hours post-treatment using BrdU incorporation. The green signal represents BrdU. Scale bar = 500 μm. ( d ) Quantification of BrdU assay data ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant. ( e ) The cell proliferation ability of C2C12 cells in the W-GA group was further evaluated using a CCK-8 assay. The data are presented as the mean ± standard deviation. NS: Not significant

Article Snippet: C2C12 myoblasts (a mouse cell line) were obtained from ScienCell Research Laboratories and cultured in Dulbecco's modified Eagle’s medium (DMEM; containing 25 mM glucose; Gibco, USA), which included 10% fetal bovine serum (Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, USA), in a humidified atmosphere at 37°C and 5% CO 2 .

Techniques: In Vitro, Cell Culture, Staining, Standard Deviation, BrdU Incorporation Assay, BrdU Staining, CCK-8 Assay

Antiapoptotic, antioxidative, and myogenic differentiation-promoting effects of W-GA. ( a ) Flow cytometry profiles showing the abundance of total C2C12 cells under various treatment conditions, along with apoptosis events in C2C12 cells under different therapeutic interventions. ( b ) Quantification of flow cytometry data for apoptotic cells ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * * p < 0.01. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. ( c ) Flow cytometry profiles showing the production of ROS in C2C12 cells under different treatment conditions. ( d ) Quantification of flow cytometry data for ROS production ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * p < 0.05. ( e ) Representative immunofluorescence image illustrating MYHC and MyoD protein expression in C2C12 myoblasts. Scale bar = 100 μm. ( f ) Quantitative analysis and intergroup comparison of myotube diameters ( n = 3). The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant, * p < 0.05, * * p < 0.01

Journal: Burns & Trauma

Article Title: Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes

doi: 10.1093/burnst/tkae059

Figure Lengend Snippet: Antiapoptotic, antioxidative, and myogenic differentiation-promoting effects of W-GA. ( a ) Flow cytometry profiles showing the abundance of total C2C12 cells under various treatment conditions, along with apoptosis events in C2C12 cells under different therapeutic interventions. ( b ) Quantification of flow cytometry data for apoptotic cells ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * * p < 0.01. The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. ( c ) Flow cytometry profiles showing the production of ROS in C2C12 cells under different treatment conditions. ( d ) Quantification of flow cytometry data for ROS production ( n = 3). The data are presented as the mean ± standard deviation. NS: Not significant, * p < 0.05. ( e ) Representative immunofluorescence image illustrating MYHC and MyoD protein expression in C2C12 myoblasts. Scale bar = 100 μm. ( f ) Quantitative analysis and intergroup comparison of myotube diameters ( n = 3). The statistical significance of differences between treatments was determined by one-way ANOVA and the Bonferroni posthoc correction. NS: Not significant, * p < 0.05, * * p < 0.01

Article Snippet: C2C12 myoblasts (a mouse cell line) were obtained from ScienCell Research Laboratories and cultured in Dulbecco's modified Eagle’s medium (DMEM; containing 25 mM glucose; Gibco, USA), which included 10% fetal bovine serum (Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, USA), in a humidified atmosphere at 37°C and 5% CO 2 .

Techniques: Flow Cytometry, Standard Deviation, Immunofluorescence, Expressing, Comparison

Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into C2C12 cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01

Journal: Journal of Biomedical Science

Article Title: Vitamin D3/VDR resists diet-induced obesity by modulating UCP3 expression in muscles

doi: 10.1186/s12929-016-0271-2

Figure Lengend Snippet: Calcitriol enhanced relative luciferase activity in a dose dependent manner. UCP3-pro-luc was transfected into C2C12 cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ). Relative luciferase activity was analyzed by Dual Luciferase Assay after stimulation with calcitriol. n = 3, compared with vehicle, *: P < 0.05; **: P < 0.01

Article Snippet: Mouse C2C12 muscle cells (C2C12), rat L6 muscle cells (L6), H-EMC-SS chondrosarcoma cells, and human embryonic kidney cells (HEK293) were purchased from JCRB Cell Bank (National Institute of Biomedical Innovation, Tokyo, Japan).

Techniques: Luciferase, Activity Assay, Transfection

Calcitriol increased UCP3 mRNA expression in muscle cells. Relative mRNA expression was detected in C2C12 cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ) using qRT-PCR. To investigate the role of calcitriol and VDR on UCP3 mRNA expression, we transfected with a control plasmid ((-) mock) or VDR expression plasmid ((+) pCMX-VDR). We also performed loss-of-function experiments using selective siRNA against UCP3 ( a ). Compared with non-transfected controls, siRNAs against UCP3 strongly reduced the expression of the UCP3. n = 3. Compared with vehicle, *; P < 0.05, **; P < 0.01. ***; P < 0.005

Journal: Journal of Biomedical Science

Article Title: Vitamin D3/VDR resists diet-induced obesity by modulating UCP3 expression in muscles

doi: 10.1186/s12929-016-0271-2

Figure Lengend Snippet: Calcitriol increased UCP3 mRNA expression in muscle cells. Relative mRNA expression was detected in C2C12 cells ( a ), L6 cells ( b ), and H-EMC-SS cells ( c ) using qRT-PCR. To investigate the role of calcitriol and VDR on UCP3 mRNA expression, we transfected with a control plasmid ((-) mock) or VDR expression plasmid ((+) pCMX-VDR). We also performed loss-of-function experiments using selective siRNA against UCP3 ( a ). Compared with non-transfected controls, siRNAs against UCP3 strongly reduced the expression of the UCP3. n = 3. Compared with vehicle, *; P < 0.05, **; P < 0.01. ***; P < 0.005

Article Snippet: Mouse C2C12 muscle cells (C2C12), rat L6 muscle cells (L6), H-EMC-SS chondrosarcoma cells, and human embryonic kidney cells (HEK293) were purchased from JCRB Cell Bank (National Institute of Biomedical Innovation, Tokyo, Japan).

Techniques: Expressing, Quantitative RT-PCR, Transfection, Control, Plasmid Preparation

A The schematic diagram of cell migration assay. C2C12 cells were seeded in the four wells in a 35-nm dish. After treatment, the culture insert was removed, then the dish was observed in a live cell workstation. B The images of cell migration at 0, 360, 1605, and 2655 min. The yellow arrows indicate the loaded cells under migration and the blue arrows indicate unloaded cells under migration. C Schematic diagram of counting the number of migrating cells. D The number of migrating cells at 24 and 48 h. E The microfilaments and LDs were marked in loaded and unloaded cells. The arrows indicate the pseudopodia in loaded cells and the arrow head indicate the pseudopodia in unloaded cells. F The number of filpopdia in E ( N = 30). * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Journal: Cell Death & Disease

Article Title: Lipid droplets contribute myogenic differentiation in C2C12 by promoting the remodeling of the acstin-filament

doi: 10.1038/s41419-021-04273-8

Figure Lengend Snippet: A The schematic diagram of cell migration assay. C2C12 cells were seeded in the four wells in a 35-nm dish. After treatment, the culture insert was removed, then the dish was observed in a live cell workstation. B The images of cell migration at 0, 360, 1605, and 2655 min. The yellow arrows indicate the loaded cells under migration and the blue arrows indicate unloaded cells under migration. C Schematic diagram of counting the number of migrating cells. D The number of migrating cells at 24 and 48 h. E The microfilaments and LDs were marked in loaded and unloaded cells. The arrows indicate the pseudopodia in loaded cells and the arrow head indicate the pseudopodia in unloaded cells. F The number of filpopdia in E ( N = 30). * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Article Snippet: The C2C12 cell line was purchased from CoWin Biosciences (#CW2915F, Beijing, China).

Techniques: Cell Migration Assay, Migration

A The rate of actin-filament remodeling. C2C12 cells were pre-treated with 400 μM of oleic acid (OA, named loaded cells) or 3% bovine serum albumin (BSA, control, named unloaded cells). For DGATi treatment, the inhibitor of DGAT1 and DGAT2 was added into medium for 12 h before OA treatment, bar, 20 μm. B The count of microfilament number per cell. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Journal: Cell Death & Disease

Article Title: Lipid droplets contribute myogenic differentiation in C2C12 by promoting the remodeling of the acstin-filament

doi: 10.1038/s41419-021-04273-8

Figure Lengend Snippet: A The rate of actin-filament remodeling. C2C12 cells were pre-treated with 400 μM of oleic acid (OA, named loaded cells) or 3% bovine serum albumin (BSA, control, named unloaded cells). For DGATi treatment, the inhibitor of DGAT1 and DGAT2 was added into medium for 12 h before OA treatment, bar, 20 μm. B The count of microfilament number per cell. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Article Snippet: The C2C12 cell line was purchased from CoWin Biosciences (#CW2915F, Beijing, China).

Techniques: Control

A Co-localization of ACTN3, microfilaments, and LDs in C2C12 cells. B The C2C12 cells were treated with cytochalasin D for 2 h. Then, the medium was replaced with a fresh medium. The LDs were isolated at 0 h, 0.5 h, 1 h, and 2 h, respectively. The ACTN3 levels were detected by Western blotting. C The LD-targeting ACTN3 plasmid was constructed by inserting a PAT domain (PLIN1 1–193aa) at the N-terminus of ACTN3. The co-localization of PAT-ACTN3-EGFP, LDs, and microfilaments in C2C12 cells was detected by a co-confocal microscope. The fluorescence intensity, along with the arrow line, is plotted in the below graphs. D The C2C12 cells (expressing PAT-ACTN3-EGFP) were treated with cytochalasin D for 2 h, then the medium was replaced with a fresh medium. The subcellular components were isolated at 0 and 1 h, respectively. The levels of EGFP were detected. ACTB was utilized as the microfilament reference protein and ATP1A was utilized as cytomembrane reference protein. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Journal: Cell Death & Disease

Article Title: Lipid droplets contribute myogenic differentiation in C2C12 by promoting the remodeling of the acstin-filament

doi: 10.1038/s41419-021-04273-8

Figure Lengend Snippet: A Co-localization of ACTN3, microfilaments, and LDs in C2C12 cells. B The C2C12 cells were treated with cytochalasin D for 2 h. Then, the medium was replaced with a fresh medium. The LDs were isolated at 0 h, 0.5 h, 1 h, and 2 h, respectively. The ACTN3 levels were detected by Western blotting. C The LD-targeting ACTN3 plasmid was constructed by inserting a PAT domain (PLIN1 1–193aa) at the N-terminus of ACTN3. The co-localization of PAT-ACTN3-EGFP, LDs, and microfilaments in C2C12 cells was detected by a co-confocal microscope. The fluorescence intensity, along with the arrow line, is plotted in the below graphs. D The C2C12 cells (expressing PAT-ACTN3-EGFP) were treated with cytochalasin D for 2 h, then the medium was replaced with a fresh medium. The subcellular components were isolated at 0 and 1 h, respectively. The levels of EGFP were detected. ACTB was utilized as the microfilament reference protein and ATP1A was utilized as cytomembrane reference protein. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Article Snippet: The C2C12 cell line was purchased from CoWin Biosciences (#CW2915F, Beijing, China).

Techniques: Isolation, Western Blot, Plasmid Preparation, Construct, Microscopy, Fluorescence, Expressing

A The C2C12 cells were treated with cytochalasin D for 2 h, then the medium was replaced with a fresh medium. The co-localization of PAT-ACTN3-EGFP and ARF1-DsRed was detected. The fluorescence intensity, along with the arrow line, is plotted in the graph below. B The co-localization of LDs and ARF1-EGFP in C2C12 cells was detected. C The rate of actin-filament remodeling in loaded cells with brefeldin A treatment and unloaded cells, bar, 20 μm. D The count of microfilament number per cell. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Journal: Cell Death & Disease

Article Title: Lipid droplets contribute myogenic differentiation in C2C12 by promoting the remodeling of the acstin-filament

doi: 10.1038/s41419-021-04273-8

Figure Lengend Snippet: A The C2C12 cells were treated with cytochalasin D for 2 h, then the medium was replaced with a fresh medium. The co-localization of PAT-ACTN3-EGFP and ARF1-DsRed was detected. The fluorescence intensity, along with the arrow line, is plotted in the graph below. B The co-localization of LDs and ARF1-EGFP in C2C12 cells was detected. C The rate of actin-filament remodeling in loaded cells with brefeldin A treatment and unloaded cells, bar, 20 μm. D The count of microfilament number per cell. * p < 0.05. Results are from three technical repeats ( N = 3) for a representative of three biological repeats ( N = 3).

Article Snippet: The C2C12 cell line was purchased from CoWin Biosciences (#CW2915F, Beijing, China).

Techniques: Fluorescence